PJP vs. ARKG
PJP (Invesco Dynamic Pharmaceuticals ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. PJP is passively managed, while ARKG is actively managed. Over the past 10 years, PJP returned 6.15%/yr vs 7.22%/yr for ARKG. A 0.60 correlation means they provide meaningful diversification when combined. PJP charges 0.58%/yr vs 0.75%/yr for ARKG.
Performance
PJP vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 2.90% return, which is significantly lower than ARKG's 17.09% return. Over the past 10 years, PJP has underperformed ARKG with an annualized return of 6.15%, while ARKG has yielded a comparatively higher 7.22% annualized return.
PJP
- 1D
- 1.20%
- 1M
- 1.29%
- YTD
- 2.90%
- 6M
- 2.29%
- 1Y
- 34.73%
- 3Y*
- 13.31%
- 5Y*
- 7.62%
- 10Y*
- 6.15%
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
PJP vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 2.90% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between PJP and ARKG is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.60 |
The correlation between PJP and ARKG has been stable across timeframes, ranging from 0.52 to 0.60 - a consistent structural relationship.
PJP vs. ARKG - Sectors Allocation Comparison
Sectors
PJP
ARKG
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
ARKG
Basic Materials
PJP
-
ARKG
-
Communication Services
PJP
-
ARKG
-
Consumer Cyclical
PJP
-
ARKG
-
Consumer Defensive
PJP
-
ARKG
-
Energy
PJP
-
ARKG
-
Financial Services
PJP
-
ARKG
Industrials
PJP
-
ARKG
-
Real Estate
PJP
-
ARKG
-
Technology
PJP
-
ARKG
-
Utilities
PJP
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. ARKG — Risk / Return Rank
PJP
ARKG
PJP vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.82 | ||
| Sortino ratioReturn per unit of downside risk | +1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.22 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | 1.95 | +1.75 |
| Martin ratioReturn relative to average drawdown | 11.55 | 4.67 | +6.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PJP | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 1.31 | +0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | -0.35 | +0.82 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | 0.18 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.13 | +0.46 |
Drawdowns
PJP vs. ARKG - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for PJP and ARKG.
Loading charts...
Drawdown Indicators
| PJP | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -83.59% | +46.53% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -27.51% | +18.07% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -51.96% | +35.69% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -80.18% | +62.67% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -83.59% | +49.64% |
Current DrawdownCurrent decline from peak | -2.94% | -69.65% | +66.71% |
Average DrawdownAverage peak-to-trough decline | -8.85% | -35.87% | +27.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 11.46% | -8.44% |
Volatility
PJP vs. ARKG - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.33%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 11.90% | -6.57% |
Volatility (6M)Calculated over the trailing 6-month period | 12.02% | 28.77% | -16.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.38% | 41.12% | -24.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 45.61% | -29.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 41.12% | -22.73% |
PJP vs. ARKG - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
PJP vs. ARKG - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.99%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
PJP Invesco Dynamic Pharmaceuticals ETF | 0.99% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
Frequently Asked Questions
PJP and ARKG have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to PJP (5.33%). In terms of maximum drawdown, PJP dropped -37.06% vs ARKG's -83.59%.
On 10-year performance, ARKG leads with 7.22% vs 6.15% for PJP. On fees, PJP is cheaper at 0.58% per year. On volatility, PJP has been the lower-risk option at 5.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKG has performed better with a 7.22% return vs 6.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PJP is cheaper with a 0.58% expense ratio, compared with 0.75% for ARKG.
PJP has the higher dividend yield at 0.99%, compared with 0.00% for ARKG.
They also come from different issuers: Invesco and ARK. Their fees differ too: 0.58% for PJP and 0.75% for ARKG.
PJP currently has the higher Sharpe Ratio (2.13 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer